function getval(val){
 var a1=val.replace(/<\/?.+?>/g,"");
 var a2=a1.replace(/ /g,"");
 return a2;
}
//document.write('http://wxzl.cogonline.com/html/CeShiZhuanLanYi/ShiBin/ZhiNaWenXian/907.html');
wx.config({
debug:  false, 
appId: 'wx85d01b1d7184c45d',
timestamp: 1716332458,
nonceStr: 'TTLE5Df74fWNYSPd',
signature: '96405e75f72528514a9e9c7dc44753ac8496e26d',
jsApiList: [ 
   'checkJsApi', 
   'onMenuShareTimeline', 
   'onMenuShareAppMessage', 
   'onMenuShareQQ', 
   'onMenuShareWeibo'
]
});
wx.ready(function () { 
	wx.onMenuShareTimeline({  
	title: 'PARP抑制剂的前世今生｜推陈出新，历经三代，终获上市', 
	link: 'http://wxzl.cogonline.com/html/CeShiZhuanLanYi/ShiBin/ZhiNaWenXian/907.html',
	imgUrl: 'http://wxzl.cogonline.com/wp/logo.jpg',
	success: function () {
		//alert('fx-ok');
	},
	cancel: function () {
		//alert('fx-no');
	}
	});
	wx.onMenuShareAppMessage({  
		title: 'PARP抑制剂的前世今生｜推陈出新，历经三代，终获上市', 
		link: 'http://wxzl.cogonline.com/html/CeShiZhuanLanYi/ShiBin/ZhiNaWenXian/907.html',
		imgUrl: 'http://wxzl.cogonline.com/wp/logo.jpg',
		desc: getval('众所周知，PARPi现已广泛应用于卵巢癌的全程管理，尤其是一线和二线的维持治疗，但PARPi的最初研发是波折的过程，历经三次药物结构的更迭，终获上市。本期文献精读特别邀请来自天津医科大学总医院的张旭红医生，解读发表在Nature Review的一篇文章，Poly(ADP-ribose) polymerase inhibition: past, present and future.            00:000:00  '),
		success: function () {
			//alert('fx-ok');
		},
		cancel: function () {
			//alert('fx-no');
		}
	});
});	
wx.error(function (res) {
	//alert(location.href.split('#')[0]);
	//alert('err:'+res.errMsg);  
});
if(location.href.indexOf("?") >= 1 ){
	location.href=location.href.substring(0,location.href.indexOf("?"));
}